Invest in Credit Risk Mutual Fund or not?

What are Credit Risk Funds? Why investors stay away from this investment? How do these funds work? How much is the risk in this investment?

GLS is a leading developer and manufacturer of select high value, non-commoditised active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management and diabetes.

New Delhi: The initial public offer of Krishna Institute of Medical Sciences Limited was subscribed 3.86 times on the last day of subscription on Friday. The Krishna Institute IPO received bids for 5,56,55,046 shares as against 1,44,13,073 shares on offer, as per NSE data.

The portion meant for Qualified Institutional Buyers(QIBs) was subscribed 5.26 times, non-institutional investors 1.89 times, and retail individual investors(RIIs) 2.89 times.

The initial public offer (IPO) comprised a fresh issue of up to Rs 200 crore and an offer for sale of up to 2,35,60,538 equity shares. The price range for the offer was at Rs 815-825 per share. Krishna Institute of Medical Sciences Ltd on Tuesday raised over Rs 955 crore from anchor investors.

The equity shares of the company are proposed to be listed on BSE and NSE. Krishna Institute of Medical Sciences (KIMS) is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of the number of patients treated and treatments offered.

Kotak Mahindra Capital Company, Axis Capital, Credit Suisse Securities (India), and IIFL Securities were the managers of the offer.

Published: June 18, 2021, 19:44 IST
Exit mobile version